Trial intelligence / Profile preview

Hormone Replacement Therapy for Frozen Shoulder in Peri- and Postmenopausal Women

NCT07278323Phase 4Recruiting

Sponsor
University of California, San Francisco
Start
Jan 2026
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of estradiol, hydroxyprogesterone caproate in adhesive capsulitis of the shoulder (AC), sponsored by University of California, San Francisco. Started Jan 2026; status: recruiting.

02

Drugs

estradiolhydroxyprogesterone caproate
03

Conditions

adhesive capsulitis of the shoulder (AC)

Beyond the preview

Go deeper on NCT07278323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07278323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call